Misonix Announces Extension And Expansion Of Distribution Agreement With Mentor Corporation

Farmingdale, NY - Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, recently announced it has extended its distribution agreement for the Lysonix 3000 Ultrasound Assisted Liposuction System with Santa Barbara, CA, based Mentor Corporation for an additional year. Under the terms of the agreement extension, Mentor retains exclusive distribution rights for Lysonix in the U.S. and gains non-exclusive rights for certain foreign markets. Minimum purchase requirements apply to both U.S. and world markets and represent significant growth over the previous year.

Mentor Corporation is a leading supplier of medical product for the global aesthetic market. Mentor develops, manufactures and markets innovative, science-based products for surgical and non-surgical medical procedures that allow patients to retain a youthful appearance while improving personal well-being.

Liposuction is a major product segment within the multi-billion dollar aesthetic procedure market, with the number of procedures in the U.S. exceeding 400,000 per year, as reported by the American Society of Plastic Surgeons. The Lysonix 3000 Ultrasound Assisted Liposuction System provides multiple benefits to both patient and physician versus other liposuction methods, including small incision sites, targeted fat removal, reduced bleeding, reduced bruising, and faster procedure time.

"Misonix is quite pleased to continue our long-term association with Mentor, a major force in the aesthetic surgery market. We look forward to continuing our collaboration in growing the ultrasound assisted liposuction market while exploring other potential applications for this valuable surgical tool," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.

SOURCE: Misonix, Inc.